Volume 22, Number 10—October 2016
Distinct Zika Virus Lineage in Salvador, Bahia, Brazil
Highlight and copy the desired format.
|EID||Naccache SN, Thézé J, Sardi SI, Somasekar S, Greninger AL, Bandeira AC, et al. Distinct Zika Virus Lineage in Salvador, Bahia, Brazil. Emerg Infect Dis. 2016;22(10):1788-1792. https://dx.doi.org/10.3201/eid2210.160663|
|AMA||Naccache SN, Thézé J, Sardi SI, et al. Distinct Zika Virus Lineage in Salvador, Bahia, Brazil. Emerging Infectious Diseases. 2016;22(10):1788-1792. doi:10.3201/eid2210.160663.|
|APA||Naccache, S. N., Thézé, J., Sardi, S. I., Somasekar, S., Greninger, A. L., Bandeira, A. C....Chiu, C. Y. (2016). Distinct Zika Virus Lineage in Salvador, Bahia, Brazil. Emerging Infectious Diseases, 22(10), 1788-1792. https://dx.doi.org/10.3201/eid2210.160663.|
Sequencing of isolates from patients in Bahia, Brazil, where most Zika virus cases in Brazil have been reported, resulted in 11 whole and partial Zika virus genomes. Phylogenetic analyses revealed a well-supported Bahia-specific Zika virus lineage, which indicates sustained Zika virus circulation in Salvador, Bahia’s capital city, since mid-2014.
Zika virus is an arthropodborne RNA virus primarily transmitted by mosquitoes of the species Aedes (1). The virus has 2 genotypes: African, found only in the continent of Africa; and Asian, associated with outbreaks in Southeast Asia, several Pacific islands, and, recently, the Americas (2). In May 2015, Brazil reported its first autochthonous cases of Zika virus infection, which occurred in northeast Brazil (3,4). As of June 30, 2016, all 27 federal states in Brazil had confirmed Zika virus transmission (http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35262&lang=en).
The rapid geographic expansion of Zika virus transmission and the virus’s association with microcephaly and congenital abnormalities (5) demand a rapid increase in molecular surveillance in areas that are most affected. Molecular surveillance is particularly relevant for regions where other mosquitoborne viruses, particularly dengue and chikungunya viruses, co-circulate with Zika virus (2); surveillance on the basis of clinical symptoms alone is highly inaccurate. Genetic characterization of circulating Zika virus strains can help determine the origin and potential spread of infection in travelers returning from Zika virus–endemic countries. Previous analyses have suggested that Zika virus was introduced in the Americas at least 1 year before the virus’s initial detection in Brazil (1). The state of Bahia, Brazil, reported most (93%) suspected Zika virus infections in Brazil during 2015 (2), including cases of Zika virus–associated fetal microcephaly (6); however, except for 1 complete genome, no genetic information from the region has been available (2,7). We report molecular epidemiologic findings resulting from 11 new complete and partial Zika virus genomes recovered from serum samples from patients at the Hospital Aliança in the city of Salvador in Bahia, Brazil.
Symptomatic patients with suspected Zika virus infection were enrolled in a research study approved by the Brazil Ministry of Health (Certificado de Apresentação para Apreciação Ética 45483115.0.0000.0046, no. 1159.184, Brazil). During April 2015–January 2016, acute Zika virus infection was diagnosed for 15 patients whose serum samples tested positive by a qualitative reverse transcription PCR (RT-PCR) by using primers targeting the nonstructural 5 gene (8). Clinical samples were retested for Zika virus positivity by using a separate quantitative RT-PCR (QuantiTect SYBR Green PCR kit; QIAGEN, Valencia, CA, USA) and primers targeting the envelope gene (9). Metagenomic next-generation sequencing libraries were constructed from serum RNA extracts, as described (10,11; Technical Appendix [PDF - 408 KB - 5 pages]). Pathogen identification from metagenomic next-generation sequencing data was performed by using the Sequence-based Ultra-Rapid Pathogen Identification bioinformatics pipeline (12; http://chiulab.ucsf.edu/surpi/). Results of the metagenomic analyses and identification of co-infections with chikungunya virus are reported elsewhere (13).
For Zika virus genome sequencing, 2 isolates (Bahia07 and Bahia09; Table) with Zika virus titers >104 copies/mL generated sufficient viral metagenomic data for complete genome assembly. For the remaining samples with lower titers, metagenomic next-generation sequencing libraries were enriched for Zika virus sequencing by using xGen biotinylated lockdown capture probes (Integrated DNA Technologies, Redwood, CA, USA) designed to tile across all sequenced Zika virus genomes >10,000 nt in GenBank (http://www.ncbi.nlm.nih.gov/genbank) as of March 1, 2016. Capture probes were curated for redundancy at a 99% nt similarity cutoff. Enrichment was performed on the metagenomic libraries in pools of 8 libraries (including Zika virus–negative serum sample controls) by using the xGen lockdown probe protocol and the SeqCap EZ Hybridization and Wash Kit (Roche, Indianapolis, IN, USA). Eleven Zika virus genomes with >40% genome recovery (mean 69.4% ± 2.0%) were assembled (Table). Distribution of single nucleotide variants across the 11 recovered genomes exhibited distinct patterns (Technical Appendix [PDF - 408 KB - 5 pages] Figure 1), indicating that the assembled genomes were unlikely to result from cross-contamination by a single high-titer Zika virus sample.
Multiple sequence alignment was performed by using MAFFT version 7 (http://mafft.cbrc.jp/alignment/software/); maximum-likelihood (ML) and Bayesian phylogenetic inferences were determined by using PhyML version 3.0 (http://www.atgc-montpellier.fr/phyml/) and BEAST version 1.8.2 (http://beast.bio.ed.ac.uk/), respectively. The best-fit model was calculated by using jModelTest2 (https://github.com/ddarriba/jmodeltest2; details in Technical Appendix [PDF - 408 KB - 5 pages]). Coding regions corresponding to the 11 complete or partial genomes from Bahia were aligned with all published and available near-complete Zika virus genomes and longer subgenomic regions (>1,500 nt) of the Asian genotype as of April 2016 (mean sequence size 8,402 nt with 1,652 distinct nucleotide site patterns). The ML phylogeny was reconstructed by using the best-fit general time-reversible nucleotide substitution model with a proportion of invariant sites (GTR+I). Statistical support for phylogenetic nodes was assessed by using a bootstrap approach with 1,000 bootstrap replicates. A Bayesian molecular clock phylogeny was estimated by using the best-fitting evolutionary model (2); specifically, a GTR+I substitution model with 3 components: a strict molecular clock, a Bayesian skyline coalescent prior, and a noninformative continuous time Markov chain reference prior for the molecular clock rate.
The isolates from patients in Salvador clustered together within 1 strongly supported clade (posterior probability 1.00, bootstrap support 100%, Bahia clade C) (Figure; Technical Appendix [PDF - 408 KB - 5 pages] Figure 2). This support is notable; most Zika virus genomes in this clade are incomplete, and uncertainty is accounted for in phylogenetic inference. The tree topology accords with previous findings (2,4,5), and time to most recent common ancestor (TMRCA) of the epidemic in the Americas is similar to that previously estimated (2) (American epidemic clade A; Figure). The overall ML and molecular clock phylogenies exhibited many well-supported internal nodes with bootstrap support >60% and posterior probability >0.80 (Figure; Technical Appendix [PDF - 408 KB - 5 pages] Figure 2), although several nodes near the ancestor of clade A were less well supported.
The updated phylogenetic analyses, including the newly identified clade C, suggest that Zika virus was introduced in Bahia during March–September 2014. An isolate from Maranhão in northeastern Brazil (≈1,000 km from Bahia) is ancestral to the Bahia clade (posterior probability 1.00, bootstrap support 74%, northeastern Brazil clade B) (Figure; Technical Appendix [PDF - 408 KB - 5 pages] Figure 2). The TMRCA of clade B (comprising the Bahia clade and the Maranhão sequence) is estimated to be September 2013–April 2014, an early stage of the epidemic. This TMRCA is consistent with the hypothesis that Zika virus in the Americas originated in Brazil (2). A previously reported sequence from Bahia (6) clustered with an isolate from Belém in the state of Pará in northern Brazil, ≈3,000 km from Bahia (posterior probability 0.99, bootstrap support 81%) (Figure; Technical Appendix [PDF - 408 KB - 5 pages] Figure 2). The patient denied history of travel, suggesting that multiple Zika virus lineages may circulate in Bahia.
Our results suggest an early introduction and presence (mid-2014) of Zika virus in the Salvador region in Bahia, Brazil. Given the size of the cluster and statistical support for it, this lineage likely represents a large and sustained chain of transmission within Bahia state. Most cases of this Zika virus lineage clustered closely to a sequence from Maranhão, and we found evidence for an additional potential introduction to Bahia from Pará state. Consequently, Zika virus in Salvador during mid-2014 was likely introduced from other regions in Brazil rather than from outside the country. Current findings of Zika virus emergence in Bahia state during mid-2014 are consistent with first-trimester viral infection in pregnant women corresponding to the initial reported cases of fetal microcephaly, which began in January 2015 (5) and peaked in November 2015.
Broader sampling across Bahia is needed to determine whether the Salvador lineage (clade C) identified in this article comprises most Zika virus cases in the state. Brazil currently faces a major public health challenge from co-circulation of Zika, dengue, and chikungunya viruses (2–4,14,15). Additional molecular surveillance in the Americas and beyond is urgently needed to trace and predict transmission of Zika virus.
Dr. Naccache is a researcher at the University of California, San Francisco; her interests are genomic assay development for clinical infectious disease diagnosis and sequencing-based characterization of emerging viruses. Dr. Thézé is a postdoctoral researcher in computational biology at the University of Oxford, UK; he is interested in viral evolution, especially the spatiotemporal dynamics of pathogen spread.
We thank multiple researchers worldwide for permission to include their unpublished Zika virus genomes in our analysis.
This study was supported in part by Fundação de Amparo a Pesquisa do Estado da Bahia, the European Research Council under the European Union’s Seventh Framework Program (FP7/2007-2013)/ERC grant agreement no. 614725-PATHPHYLODYN, National Institutes of Health grants R01-HL105704 and R21-AI120977 (C.Y.C.), and a viral discovery award from Abbott Laboratories, Inc. (C.Y.C.). This study was made possible by the generous support of the American people through the United States Agency for International Development Emerging Pandemic Threats Program-2 PREDICT-2 (Cooperative Agreement No. AID-OAA-A-14-00102).
- Musso D, Gubler DJ. Zika virus. Clin Microbiol Rev. 2016;29:487–524.
- Faria NR, Azevedo Rdo S, Kraemer MU, Souza R, Cunha MS, Hill SC, Zika virus in the Americas: early epidemiological and genetic findings. Science. 2016;352:345–9.
- Campos GS, Bandeira AC, Sardi SI. Zika virus outbreak, Bahia, Brazil. Emerg Infect Dis. 2015;21:1885–6.
- Zanluca C, Melo VC, Mosimann AL, Santos GI, Santos CN, Luz K. First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz. 2015;110:569–72.
- Rubin EJ, Greene MF, Baden LR. Zika virus and microcephaly. N Engl J Med. 2016;374:984–5.
- Kleber de Oliveira W, Cortez-Escalante J, De Oliveira WT, do Carmo GM, Henriques CM, Coelho GE, Increase in reported prevalence of microcephaly in infants born to women living in areas with confirmed Zika virus transmission during the first trimester of pregnancy—Brazil, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:242–7.
- Giovanetti M, Faria NR, Nunes MR, de Vasconcelos JM, Lourenço J, Rodrigues SG, Zika virus complete genome from Salvador, Bahia, Brazil. Infect Genet Evol. 2016;41:142–5.
- Balm MN, Lee CK, Lee HK, Chiu L, Koay ES, Tang JW. A diagnostic polymerase chain reaction assay for Zika virus. J Med Virol. 2012;84:1501–5.
- Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14:1232–9.
- Chiu CY, Bres V, Yu G, Krysztof D, Naccache SN, Lee D, Genomic assays for identification of chikungunya virus in blood donors, Puerto Rico, 2014. Emerg Infect Dis. 2015;21:1409–13.
- Greninger AL, Naccache SN, Messacar K, Clayton A, Yu G, Somasekar S, A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012–14): a retrospective cohort study. Lancet Infect Dis. 2015;15:671–82.
- Naccache SN, Federman S, Veeraraghavan N, Zaharia M, Lee D, Samayoa E, A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples. Genome Res. 2014;24:1180–92.
- Sardi SI, Somasekar S, Naccache SN, Bandeira AC, Tauro LB, Campos GS, Co-infections from Zika and chikungunya virus in Bahia, Brazil identified by metagenomic next-generation sequencing. J Clin Microbiol. In press 2016.
- Kraemer MU, Sinka ME, Duda KA, Mylne AQ, Shearer FM, Barker CM, The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus. eLife. 2015;4:e08347.
- Nunes MR, Faria NR, de Vasconcelos JM, Golding N, Kraemer MU, de Oliveira LF, Emergence and potential for spread of chikungunya virus in Brazil. BMC Med. 2015;13:102.
- Figure. Timeframe of Zika virus outbreaks in the Americas. A molecular clock phylogeny is shown with the Zika virus outbreak lineage estimated from complete and partial (>1,500 nt) coding region sequences....
- Table. Clinical information for isolates from serum samples of patients with acute symptomatic Zika virus infection
- Technical Appendix. Details of library construction and next-generation sequencing methods, phylogenetic analyses, and data availability for this study, including supplemental figures. 408 KB
1These first authors contributed equally to this article.
Please use the form below to submit correspondence to the authors or contact them at the following address:
Charles Y. Chiu, University of California, San Francisco, 185 Berry St, Box # 0134, UCSF China Basin, San Francisco, CA 94107, USA
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: September 20, 2016
- Page last updated: September 20, 2016
- Page last reviewed: September 20, 2016
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)